Why has the US COVID-19 vaccine roll out been so slow?

COVID-19 vaccines have been the subject of speculation and anticipation for months—so why hasn’t the US made more progress on vaccination?

It’s been three weeks since the COVID-19 vaccines began arriving at hospitals, clinics, and pharmacies. Operation Warp Speed—the US vaccination development, testing, and distribution effort—had made 20 million vaccine doses available by the end of 2020. Yet the US is only approaching 5.5 million vaccines administered so far.

Public health experts, policymakers, and the leaders of Operation Warp Speed agree: The US must pick up the pace of vaccination.

Tinglong Dai, an associate professor at Johns Hopkins University’s Carey Business School, has closely followed the rollout of vaccines in the US.

Here, he shares insights on what’s working, what needs to be improved, and how the fractured and decentralized US health care system might be able to prepare for future national health care crises:

The post Why has the US COVID-19 vaccine roll out been so slow? appeared first on Futurity.

from Futurity https://ift.tt/35xIT15